Cargando…

Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival

Advanced hepatitis B virus (HBV)‐related hepatocellular carcinoma HCC with poor prognosis is often associated with chronic inflammation, immune tolerance, and marked heterogeneity. The interleukin‐6 (IL‐6)/JAK/STAT3 signal pathways play multiple regulatory roles in modulating inflammation and immuni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Shu‐Kui, Li, Qing, Ming Xu, Jian, Liang, Jun, Cheng, Ying, Fan, Ying, Jiang, Jun, Ye, Hao, Tao, Huimin, Li, Lian, Zheng, Limin, Wei, Zhaohui, Li, Shu, Meng, Kun, Ye, Bin, Sun, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648021/ https://www.ncbi.nlm.nih.gov/pubmed/32889778 http://dx.doi.org/10.1111/cas.14641

Ejemplares similares

First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers
por: Fan, Ying, et al.
Publicado: (2019)

Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation
por: Tao, Huimin, et al.
Publicado: (2021)

From immune equilibrium to immunodynamics
por: Chen, Xiaoping
Publicado: (2022)

Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells
por: Lu, Pei-Hua, et al.
Publicado: (2017)

Immunodynamics of explanted human tumors for immuno‐oncology
por: Dubuisson, Agathe, et al.
Publicado: (2020)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)

A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
por: Li, Haowen, et al.
Publicado: (2020)

Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension
por: Tabeling, Christoph, et al.
Publicado: (2022)

Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2023)

Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology
por: Xue, Zhong, et al.
Publicado: (2023)

Dose finding for new vaccines: The role for immunostimulation/immunodynamic modelling
por: Rhodes, Sophie J., et al.
Publicado: (2019)

Quo Vadis? Immunodynamics of Myeloid Cells after Myocardial Infarction
por: Moggio, Aldo, et al.
Publicado: (2022)

The Antiosteoporotic Activity of Central-Icaritin (CIT) on Bone Metabolism of Ovariectomized Rats
por: Jiang, Jun, et al.
Publicado: (2014)

Immunodynamics of Th17 cells in HIV-1 subtype ‘C’ infection
por: Vajpayee, Madhu, et al.
Publicado: (2012)

Reverse immunodynamics: a new method for identifying targets of protective immunity
por: Spensley, Katrina J., et al.
Publicado: (2019)

Icaritin ameliorates RANKL-mediated osteoclastogenesis and ovariectomy-induced osteoporosis
por: Huang, Jun-ming, et al.
Publicado: (2023)

A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
por: Zhao, Hong, et al.
Publicado: (2015)

Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma
por: Li, Hui, et al.
Publicado: (2021)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making
por: Rhodes, Sophie J., et al.
Publicado: (2018)

Tracking immunodynamics by identification of S-G(2)/M-phase T cells in human peripheral blood()()
por: Muñoz-Ruiz, Miguel, et al.
Publicado: (2020)

A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology
por: Sprooten, Jenny, et al.
Publicado: (2022)

Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice
por: Nath, Pulak R., et al.
Publicado: (2022)

Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling
por: Rhodes, Sophie, et al.
Publicado: (2022)

Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy
por: Yang, Xiao-Jing, et al.
Publicado: (2019)

Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells
por: Wang, Shikang, et al.
Publicado: (2019)

Icaritin inhibits decidualization of endometrial stromal cells
por: Le, Aiwen, et al.
Publicado: (2017)

Comprehensive investigation of p53, p21, nm23, and VEGF expression in hepatitis B virus-related hepatocellular carcinoma overall survival after hepatectomy
por: Zhu, Guang-Zhi, et al.
Publicado: (2020)

Does homologous reinfection drive multiple-wave influenza outbreaks? Accounting for immunodynamics in epidemiological models()
por: Camacho, A., et al.
Publicado: (2013)

Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells
por: Tong, Jing-Shan, et al.
Publicado: (2011)

Icaritin inhibits PD‐L1 expression by Targeting Protein IκB Kinase α
por: Mo, Dongliang, et al.
Publicado: (2021)

Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review
por: Zhu, Jie, et al.
Publicado: (2020)

Icaritin Attenuates Lipid Accumulation by Increasing Energy Expenditure and Autophagy Regulated by Phosphorylating AMPK
por: Wu, Yue, et al.
Publicado: (2021)

Highly efficient bioconversion of icariin to icaritin by whole-cell catalysis
por: Lin, Yu, et al.
Publicado: (2023)

Evaluation of Eight Different Clinical Staging Systems Associated with Overall Survival of Chinese Patients with Hepatocellular Carcinoma
por: Zhao, Jian-Jun, et al.
Publicado: (2015)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

Bioactive PLGA/tricalcium phosphate scaffolds incorporating phytomolecule icaritin developed for calvarial defect repair in rat model
por: Shi, Guang-Sen, et al.
Publicado: (2020)

Pharmacokinetics and metabolism of icaritin in rats by UPLC‐MS/MS
por: Huang, Zhen‐Wu, et al.
Publicado: (2019)

Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation
por: Zhang, Chao, et al.
Publicado: (2016)

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials
por: Kohrt, Holbrook E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6726vnp9op6gm70s8kg9cr3jqb